| Ambetter Health Texas Superior Marketplace Clinical | Galcanezumab-gnlm | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Garadacimab-gxii | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Gemcitabine Intravesical System | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Gemtuzumab Ozogamicin | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Glepaglutide | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Goserelin Acetate | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Halcinonide | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Halobetasol Propionate | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Hyaluronate Derivatives | 2025-11-01 |